Latest Asx Listings News

Dundas Minerals has secured $2.5 million to fund extensive drilling across its Western Australian gold portfolio, exercised its option to acquire the Rockland mining lease, and expanded the Romano project with a new exploration licence application near Gruyere.

Cosmos Exploration is advancing its Bolivian lithium ambitions by exercising its option to acquire 100% of EAU Lithium and raising A$5 million to fund exploration and acquisition costs.

FMR Resources wraps up Phase I drilling at its Chilean Llahuin Project, revealing extensive mineralised porphyry zones, while initial assays from Canada’s Goshen Prospect affirm a copper system. The company holds $3.1 million in cash and plans Phase II drilling.

Westgold Resources maintained FY26 gold production guidance with 93,145oz in Q3, backed by a record A$7,080/oz gold price and a robust A$285M underlying cash build. The company approved a $145M expansion of its Higginsville processing hub to boost capacity and cut costs.

Maritana Minerals has confirmed robust economics and high-grade drilling results at its Black Swan gold project near Kalgoorlie, backed by a $175 million capital raise and a $35 million asset divestment.

New Frontier Minerals has secured technical approval for its Big One Copper Deposit Mining Lease Application, updated exploration targets across multiple copper prospects, and expanded its rare earths footprint in Australia and Canada.

OncoSil Medical reported a 60% year-on-year increase in dose sales in Q3 FY26, boosted by expanding treatment centres and advancing clinical trials, while cost-cutting and a new manufacturing facility aim to underpin growth.

Venari Minerals has achieved a key metallurgical milestone by producing 99.5% pure battery-grade lithium carbonate from its Red Mountain Project in Nevada, highlighting its potential as a domestic US lithium chemical source alongside valuable by-products.

Stakk Ltd has reported a striking 186% quarter-on-quarter revenue jump to A$5.52 million in Q1 2026, driven by converting contracted clients into active billing and new engagements, underpinning strong recurring revenue and cash flow.

Bio-Gene Technology is progressing critical toxicology studies for Flavocide with a targeted APVMA submission in March 2027, while forging a strategic partnership to launch Qcide insecticides in Japan by late 2026.

Kuniko Limited has launched a prospectus offering over 51 million new options following a $3.75 million share placement, aiming to facilitate secondary trading and potential future capital raising through option exercises.

Babylon Pump & Power’s shares remain suspended from ASX trading as the company delays disclosure of a material transaction and capital raising, prolonging market uncertainty beyond the initial deadline.